Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
Twelve doctoral candidates traveled from the Ithaca campus and Weill Cornell Medicine in New York City to Capitol Hill April 17 for the annual Cornell Ph.D. Student Advocacy Day.
Neuroscientist Gary Gibson, Ph.D. ’73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer’s disease on his office wall.
The image is a memento of Gibson’s breakthrough…
Cornell celebrated the life of Charles F. “Chuck” Feeney ’56, founding chairman of The Atlantic Philanthropies, during an event April 19 at Cornell Tech to commemorate the university’s most generous donor and officially name the main thoroughfare of the New York City campus in his honor.
Nicola Dell, associate professor at the Jacobs Technion-Cornell Institute at Cornell Tech, and novelist Ling Ma, MFA ’16, have been awarded 2024 MacArthur Foundation fellowships — more commonly known as “genius grants.”
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
The installation designed by AAP's Jennifer Newsom and Tom Carruthers is one of nearly 200 artworks featured in the Metropolitan Museum of Art's "Flight into Egypt: Black Artists and Ancient Egypt, 1876-Now" exhibition, open through Feb. 17.
A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, the Rockefeller University and the Icahn School of Medicine at Mount Sinai.
An FDA-approved drug used in humans has been found to inhibit the growth of oral squamous cell carcinomas in dogs - with one dog’s tumor nearly disappearing in a matter of weeks.